Global Prevalence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis
- PMID: 38423346
- PMCID: PMC11344691
- DOI: 10.1016/j.cgh.2024.02.018
Global Prevalence of Pancreatic Cystic Lesions in the General Population on Magnetic Resonance Imaging: A Systematic Review and Meta-analysis
Abstract
Background & aims: Understanding the burden of pancreatic cystic lesions (PCLs) in the general population is important for clinicians and policymakers. In this systematic review, we sought to estimate the global prevalence of PCLs using magnetic resonance imaging (MRI) and to investigate factors that contribute to its variation.
Methods: We searched MEDLINE, EMBASE, and Cochrane Central, from database inception through February 2023. We included full-text articles that reported the prevalence of PCLs using MRI in the general population. A proportional meta-analysis was performed, and the prevalence of PCLs was pooled using a random-effects model.
Results: Fifteen studies with 65,607 subjects were identified. The pooled prevalence of PCLs was 16% (95% confidence interval [CI], 13%-18%; I2 = 99%), most of which were under 10 mm. Age-specific prevalence of PCLs increased from 9% (95% CI, 7%-12%) at 50 to 59 years, to 18% (95% CI, 14%-22%) at 60 to 69 years, 26% (95% CI, 20%-33%) at 70 to 79 years, and 38% at 80 years and above (95% CI, 25%-52%). There was no difference in prevalence between sexes. Subgroup analysis showed higher PCL prevalence when imaging findings were confirmed by independent radiologist(s) (25%; 95% CI, 16%-33%) than when chart review alone was used (5%; 95% CI, 4%-7%; P < .01). There was no independent association of PCL prevalence with geographic location (Europe, North America, or Asia), MRI indication (screening vs evaluation of non-pancreatic pathology), enrollment period, sample size, magnet strength (1.5 vs 3 tesla), and MRI sequence (magnetic resonance cholangiopancreatography vs no magnetic resonance cholangiopancreatography).
Conclusion: In this systematic review, the global prevalence of PCLs using a highly sensitive noninvasive imaging modality ranged between 13% and 18%.
Keywords: Burden; Epidemiology; Pancreas Cyst; Prevalence; Radiology.
Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Machicado J has served as a speaker for Maunea Kea Technologies. Krishna SG ‒ research grant support (investigator-initiated studies) from Mauna Kea Technologies, Paris, France, and Taewoong Medical, USA.
Similar articles
-
Percentage of Pancreatic Cysts on MRI With a Pancreatic Carcinoma: Systematic Review and Meta-Analysis.J Magn Reson Imaging. 2024 Sep;60(3):1063-1075. doi: 10.1002/jmri.29168. Epub 2023 Dec 5. J Magn Reson Imaging. 2024. PMID: 38053468
-
Negative effect of fatty liver on visualization of pancreatic cystic lesions at screening transabdominal ultrasonography.J Eval Clin Pract. 2020 Feb;26(1):256-261. doi: 10.1111/jep.13138. Epub 2019 Apr 22. J Eval Clin Pract. 2020. PMID: 31012194
-
Prevalence of pancreatic cystic lesions detected by magnetic resonance imaging in the Chinese population.J Gastroenterol Hepatol. 2019 Sep;34(9):1656-1662. doi: 10.1111/jgh.14658. Epub 2019 Apr 14. J Gastroenterol Hepatol. 2019. PMID: 30883900
-
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals.Pancreatology. 2019 Jan;19(1):2-9. doi: 10.1016/j.pan.2018.11.014. Epub 2018 Nov 28. Pancreatology. 2019. PMID: 30503370
-
Difference analysis in prevalence of incidental pancreatic cystic lesions between computed tomography and magnetic resonance imaging.BMC Med Imaging. 2019 May 24;19(1):43. doi: 10.1186/s12880-019-0341-5. BMC Med Imaging. 2019. PMID: 31126251 Free PMC article.
Cited by
-
Prevalence of incidentally detected pancreatic cysts on magnetic resonance imaging in an adult population in Latin America.Radiol Bras. 2025 Apr 14;58:e20240103. doi: 10.1590/0100-3984.2024.0103. eCollection 2025 Jan-Dec. Radiol Bras. 2025. PMID: 40264500 Free PMC article.
-
Evolving techniques in the endoscopic evaluation and management of pancreas cystic lesions.Curr Opin Gastroenterol. 2025 Sep 1;41(5):339-347. doi: 10.1097/MOG.0000000000001119. Epub 2025 Jul 16. Curr Opin Gastroenterol. 2025. PMID: 40682403 Review.
-
Thermal Liquid Biopsy: A Promising Tool for the Differential Diagnosis of Pancreatic Cystic Lesions and Malignancy Detection.Cancers (Basel). 2024 Nov 30;16(23):4024. doi: 10.3390/cancers16234024. Cancers (Basel). 2024. PMID: 39682210 Free PMC article.
-
Early Detection of Pancreatic Cancer: Current Advances and Future Opportunities.Biomedicines. 2025 Jul 15;13(7):1733. doi: 10.3390/biomedicines13071733. Biomedicines. 2025. PMID: 40722803 Free PMC article. Review.
-
Towards automating risk stratification of intraductal papillary mucinous Neoplasms: Artificial intelligence advances beyond human expertise with confocal laser endomicroscopy.Pancreatology. 2025 May 21:S1424-3903(25)00107-3. doi: 10.1016/j.pan.2025.05.011. Online ahead of print. Pancreatology. 2025. PMID: 40447463
References
-
- Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2023. Epub 20231228. - PubMed
-
- Vege SS, Ziring B, Jain R, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148(4):819–22; quize12–3. - PubMed
-
- Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17(5):738–53. Epub 20170713. - PubMed
-
- Elta GH, Enestvedt BK, Sauer BG, et al. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol. 2018;113(4):464–79. Epub 20180227. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical